1. Home
  2. HOTH vs EFSH Comparison

HOTH vs EFSH Comparison

Compare HOTH & EFSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOTH
  • EFSH
  • Stock Information
  • Founded
  • HOTH 2017
  • EFSH 1948
  • Country
  • HOTH United States
  • EFSH United States
  • Employees
  • HOTH N/A
  • EFSH N/A
  • Industry
  • HOTH Biotechnology: Pharmaceutical Preparations
  • EFSH Professional Services
  • Sector
  • HOTH Health Care
  • EFSH Consumer Discretionary
  • Exchange
  • HOTH Nasdaq
  • EFSH Nasdaq
  • Market Cap
  • HOTH 4.9M
  • EFSH 4.2M
  • IPO Year
  • HOTH 2019
  • EFSH N/A
  • Fundamental
  • Price
  • HOTH $1.50
  • EFSH $0.23
  • Analyst Decision
  • HOTH Strong Buy
  • EFSH
  • Analyst Count
  • HOTH 4
  • EFSH 0
  • Target Price
  • HOTH $4.75
  • EFSH N/A
  • AVG Volume (30 Days)
  • HOTH 25.5M
  • EFSH 3.9M
  • Earning Date
  • HOTH 11-12-2024
  • EFSH 11-19-2024
  • Dividend Yield
  • HOTH N/A
  • EFSH N/A
  • EPS Growth
  • HOTH N/A
  • EFSH N/A
  • EPS
  • HOTH N/A
  • EFSH N/A
  • Revenue
  • HOTH N/A
  • EFSH $69,415,140.00
  • Revenue This Year
  • HOTH N/A
  • EFSH N/A
  • Revenue Next Year
  • HOTH N/A
  • EFSH N/A
  • P/E Ratio
  • HOTH N/A
  • EFSH N/A
  • Revenue Growth
  • HOTH N/A
  • EFSH 228.22
  • 52 Week Low
  • HOTH $0.58
  • EFSH $0.20
  • 52 Week High
  • HOTH $3.80
  • EFSH $820.95
  • Technical
  • Relative Strength Index (RSI)
  • HOTH 58.81
  • EFSH 39.61
  • Support Level
  • HOTH $1.50
  • EFSH $0.22
  • Resistance Level
  • HOTH $1.71
  • EFSH $0.32
  • Average True Range (ATR)
  • HOTH 0.45
  • EFSH 0.04
  • MACD
  • HOTH 0.04
  • EFSH 0.22
  • Stochastic Oscillator
  • HOTH 25.54
  • EFSH 15.83

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.

About EFSH 1847 Holdings LLC

1847 Holdings LLC is a diversified holding company. It operates in Four segments: Retail and appliances, Retail and Eyewear, Construction, and Automotive Supplies. The company generates maximum revenue from the Construction segment. The firm, through its subsidiaries, provides a wide range of land application services and sells equipment and parts, primarily to the agricultural, construction, and lawn and garden industries.

Share on Social Networks: